GH Research Reports Third Quarter 2026 Financial Results and Provides Business Update

DUBLIN, Nov. 13, 2026 (GLOBE NEWSWIRE) -- GH Research PLC NASDAQ:GHRS, a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today reported financial results for the quarter ended September 30, 2026, and…